The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2021 | CAR-T therapy for lung cancer
Adam Schoenfeld, MD, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the need for improved therapies for patients with lung cancer and the potential role of chimeric antigen receptor T-cell (CAR-T) therapy, which has shown promising results in hematological malignancies. Dr Schoenfeld also highlights challenges of CAR-T therapy which are unique to solid tumors. This video was recorded at the virtual European Lung Cancer Congress (ELCC) 2021.
Disclosures
None
